{"id":"W4397007666","doi":"10.1016/j.esmoop.2024.103102","title":"114P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Long-term efficacy and safety analysis of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Chemotherapy; Fixed-dose combination; Breast cancer; Pharmacology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002204037,0.0002339106,0.0005999943,0.00008930892,0.0001721649,0.0001147619,0.0002819056,0.00007817646,0.00001791551],"category_scores_gemma":[0.00002169418,0.0001752666,0.00007574965,0.0003567307,0.0001360952,0.0000284777,0.0003139303,0.00007728661,1.311372e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001686122,"about_ca_system_score_gemma":0.0001491454,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007814986,"about_ca_topic_score_gemma":0.007929233,"domain_scores_codex":[0.9986314,0.0001489832,0.0003790301,0.0005234962,0.000134605,0.0001824798],"domain_scores_gemma":[0.9992999,0.0001031364,0.000173254,0.00025047,0.000128169,0.00004510665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3574264,0.01724973,0.2017019,0.0004236651,0.02756307,0.00008639403,0.03780933,0.0007437359,0.0326389,0.00005028666,0.0002399965,0.3240667],"study_design_scores_gemma":[0.1486534,0.002209275,0.8390725,0.0002255469,0.001879713,0.00004263173,0.001016218,0.001360497,0.005218051,0.000006485764,0.00002696425,0.0002887798],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994056,0.0009322122,0.00009964585,0.000397203,0.00008302736,0.003941794,0.0004318272,0.000005577625,0.00005267059],"genre_scores_gemma":[0.9987168,0.0005643204,0.00003669701,0.00004628607,0.00002204334,0.0003270133,0.0001232462,0.00002612157,0.0001375071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6373706,"threshold_uncertainty_score":0.9987921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01416510392552033,"score_gpt":0.3308973171457195,"score_spread":0.3167322132201991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}